Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

NCT01608815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Salmonella Infections
Typhoid Fever
Bacterial Infections

Interventions

BIOLOGICAL: Typhoid Vi polysaccharide

Sponsor

Sanofi Pasteur, a Sanofi Company